Clinical manifestations of heterozygous familial hipercholesterolaemia in Spain. Report of 301 cases from the central and northern areas;Manifestaciones clínicas de la hipercolesterolemia familiar heterozigota en España. Estudio de 301 casos de la zona centro y norte

Medicina Clinica

Volumn 114, Issue 2, 2000, Pages 50-51

  Garcés, Carmen ^a   Rodríguez Artalejo, Fernando ^h   Serrano, Adalberto ^b   González Bonillo, José ^c   Almagro, Fatima ^d   Garrido, Juan Antonio ^e   Zúñiga, Manuel ^f   De Oya, Manuel ^a,g  

^a Fundación Jiménez Díaz   (Spain)

^b Centro de Salud Rekalde   (Spain)

^c Centro de Salud Santo Grial   (Spain)

^d Hospital de Guipuzcoa   (Spain)

^e Universidad de La Coruña   (Spain)

^f HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^g Fundación Jiménez Díaz   (Spain)

^h NONE

Author keywords

Familial hipercolesterolemia; Xanthomas

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; EYELID DISEASE; FEMALE; GENETICS; HETEROZYGOTE; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; MALE; MIDDLE AGED; SENILE ARCH; SPAIN; XANTHOMATOSIS;

ADULT; AGED; ARCUS SENILIS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; EYELID DISEASES; FEMALE; HETEROZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; SPAIN; TRIGLYCERIDES; XANTHOMATOSIS;

EID: 0040520535     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(00)71186-9     Document Type: Article

References (10)

1. Dammerman M, Breslow JL. Generic basis of lipoprotein disorders. Circulation 1995; 91: 505-512.
2. Goldstein JL, Hobbs HH, Brown MS. Familia hypercholesterolemia. En: Scriver CR, Beaudet AL. Sly WS, Valle D, editores. The metabolic basis of inherited disease (7. ed.). Nueva York: McGraw-Hill, 1995: 1981-2030.
3. Schuster H, Luft FC. Clinical criteria versus DNA diagnosis in heterozygous familial hypercolesterolemia. Is molecular diagnosis superior to clinical diagnosis? Arterioscler Thromb Vasc Biol 1998; 18: 331-332.
4. Vuorio AF, Turtola H, Piilahti KM, Repo P, Kanninen T, Kontula K. Familial hypercholesterolemia in the Finnish North Karelia. A molecular clinical, and genealogical study. Arterioscler Thromb Vasc Biol 1997; 17: 3127-3133.
5. Alonso-Villaverde CA, Sarda P, Vallbé JC, Heras M, Pérez-Jiménez F, Pedro-Botet JC et al. Manifestaciones clinicas de la hipercolesterolemia familiar en una poblacion mediterránea. Med Clin (Barc) 1999; 113: 521-525.
6. Sundberg EE, Illingworth DR. Effect of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells patients with heterozygous familial hypercholesterolemia. Proc Natl Acad Sci USA 1983; 80: 7631-7635.
7. De Cya M, Nuño J, Azpeitia AG, Villasante JG. Familial hypercholesterolemia: mechanism of inheritance. Diabetes & Metabolism 1980; 6: 181-188.
8. Hoeg JM. Homozygous familial hypercholesterolemia: a paradigm for phenotypic variation. Am J Cardiol 1993; 72: D11-D14.
9. Balaguer I, Duarte G. Hipercolesterolemia familiar xantomatosa y cardiopatĩa isquémica. CVR & R 1981; 2: 266-271.
10. Schrott HG, Goldstein JL, Hazzard WR, McGoodwin MM, Motulsky AG. Familial hypercholesterolemia in a large kindred. Evidence for a monogenic mechanism. Ann Intern Med 1972; 76: 711-720.